Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and Social Cognition in Children With ADHD: Impact of Methylphenidate
NCT03788902Completed
- Sponsor
- Shalvata Mental Health Center
- Start
- Feb 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Shalvata Mental Health Center. Primary endpoints: Theory of Mind test score at 20 minutes, Faux-Pas Recognition test score at 15 minutes and 1 more. Started Feb 2014; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT03788902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03788902.